Suven and Cohance Merger to Drive Revenue and Market Expansion ...Middle East

Devdiscourse - Opinion
Suven and Cohance Merger to Drive Revenue and Market Expansion
Suven Pharmaceuticals and Cohance Lifesciences are setting ambitious targets following their merger, aiming to more than double their combined revenue to approximately Rs 6,000 crore by FY29. The strategy involves significant organic and inorganic growth endeavors, according to Prasada Raju, Managing Director of Suven Pharma.

Read More Details
Finally We wish PressBee provided you with enough information of ( Suven and Cohance Merger to Drive Revenue and Market Expansion )

Also on site :